Wehner v. Genentech, Inc.

CourtDistrict Court, N.D. California
DecidedJune 14, 2021
Docket3:20-cv-06894
StatusUnknown

This text of Wehner v. Genentech, Inc. (Wehner v. Genentech, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wehner v. Genentech, Inc., (N.D. Cal. 2021).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 MATTHEW WEHNER, Case No. 20-cv-06894-WHO

8 Plaintiff, ORDER GRANTING IN PART AND DENYING IN PART MOTION TO 9 v. DISMISS FIRST AMENDED COMPLAINT; RULING ON 10 GENENTECH, INC., et al., DISCOVERY DISPUTE 11 Defendants. Re: Dkt. Nos. 51, 57

12 Plaintiff Matthew Wehner, a participating employee of the U.S. Roche 401(k) Savings 13 Plan (the “Plan” or “Roche Plan”), brings this class action under the Employee Retirement Income 14 Security Act (“ERISA”), 29 U.S.C. § 1132, against defendants Genentech, Inc. (“Genentech”) and 15 the U.S. Roche DC Fiduciary Committee (“Committee”) for breach of their fiduciary duties and 16 related breaches of applicable law. On February 9, 2021, I granted defendants’ motion to dismiss 17 the Complaint for failure to state a claim with leave to amend. Defendants now move to dismiss 18 the First Amended Complaint. 19 Out of the fifteen market comparators Wehner provides for his excessive fee claim, the 20 Danaher Corporation & Subsidiaries Savings Plan (“Danaher Plan”) sufficiently establishes an 21 apples-to-apples comparison to the Roche Plan. Both plans utilized Fidelity Workplace Services 22 LLC (“Fidelity”) as their recordkeeper to perform the same services to roughly the same amount 23 of plan participants, yet the Danaher Plan deducted significantly less in fess compared to the 24 Roche Plan. These allegations raise a plausible inference that defendants breached their fiduciary 25 duty of prudence by charging excessive recordkeeping and administrative fees. 26 Imprudence, however, cannot be reasonably inferred from Wehner’s conclusory 27 1 TDFs”) and selection of Russell Investment Management Company (“Russell”) as the investment 2 manager of those funds. The duty of loyalty claim based on defendants’ use of a master trust 3 structure and continued relationship with Russell is also insufficiently pleaded. The duty to 4 monitor claim is derivative of the underlying breaches and only succeeds to the extent it is based 5 on the plausibly pleaded excessive fee claim. For these reasons, defendants’ motion to dismiss is 6 DENIED in part and GRANTED in part. 7 BACKGROUND 8 The allegations in the original Complaint are detailed in my previous order, which I 9 incorporate by reference here. See Order Granting Motion to Dismiss with Leave to Amend 10 (“February 2021 Order”) [Dkt. No. 45]. The amended pleading retains some of those theories and 11 adds others. See First Amended Complaint (“FAC”) [Dkt. No. 46]. 12 Wehner is a former employee of Genentech and a current participant in the Roche Plan. 13 FAC ¶ 9. Genentech is the Plan sponsor and a fiduciary charged with administering the Plan. Id. 14 ¶ 10. Genentech assembled the Committee and appointed Committee members to administer the 15 Plan on Genentech’s behalf, all of whom are also Plan fiduciaries. Id. ¶¶ 11–12.1 The Plan’s 16 fiduciaries hold the Plan’s assets in a master trust, the Roche U.S. Retirement Plans Master Trust 17 (“Master Trust”), sponsored by Genentech. Id. ¶ 67. A master trust is a trust “in which assets of 18 more than one plan sponsored by a single employer or by a group of employers under common 19 control are held.” See Declaration of William G. Gaede, III in Support of Defendants’ Motion to 20 Dismiss (“Gaede Decl.”) [Dkt. No. 51-2], Ex. 6 (2018 Instructions for Form 5500) at 10.2 As of 21 December 31, 2019, the Plan had 34,178 participants with account balances and assets totaling just 22 under $9.4 billion, placing it in the top 1% of all defined contribution plans in the United States. 23 FAC ¶¶ 3–4. 24 Wehner asserts two causes of action in the FAC: (i) defendants’ breach of the duties of 25 1 On June 8, 2021, Wehner agreed to voluntarily dismiss Committee members David McDede, 26 Judy Embry, Kevin Marks, Edward Harrington, Frederick Kentz, Steve Krognes, Jorge Glascock, and Ivor Solomon as individual defendants in this suit. Joint Stipulation [Dkt. No. 60]. 27 1 prudence and loyalty; and (ii) a derivative claim alleging Genentech’s failure to monitor 2 fiduciaries and co-fiduciary breaches. For his first cause of action, Wehner alleges that defendants 3 breached their fiduciary duty of prudence to the Plan in two ways: (i) by imposing unreasonable 4 recordkeeping and administrative fees that were directly deducted from the Plan participants’ 5 accounts and by an undisclosed indirect fee charged as a result of the Master Trust structure; and 6 (ii) by retaining an allegedly underperforming investment fund, the Roche TDFs, and selecting 7 Russell to manage those funds despite its poor reputation and performance.3 8 Wehner contends that virtually all “large” defined contribution plans, including the Roche 9 Plan, hire one Retirement Plan Service (“RPS”) provider to provide what he calls the “essential 10 Recordkeeping & Administrative” (“RK&A”) services for the retirement plan. FAC ¶¶ 38–39. 11 He calculates that the Roche Plan directly deducted an average of $54 per participant for these 12 services and provides fifteen market comparators to show that national recordkeepers, including 13 Fidelity (the Plan’s own recordkeeper), could and would have provided the exact same services to 14 the Plan for approximately $30. Id. ¶¶ 41, 112–21. 15 As a result of the Master Trust structure, Wehner alleges that Plan participants paid 16 additional indirect administrative fees of roughly $120 per participant in 2018 and paid similarly 17 high amounts for such “unnecessary” Master Trust services in each year of the class period 18 (between 2015 and 2019). Id. ¶ 117. Adding the $120 per participant administrative fee to the 19 average per participant fee of $54 during the class period, he alleges that Plan participant paid 20 almost six (6) times the amount that it should have for RK&A services. Id. This figure does not 21 consider the amount of undisclosed revenue sharing and other indirect compensation that 22 defendants paid to Fidelity. Id. ¶ 116. “Once the amount of Fidelity’s revenue sharing is 23 disclosed in discovery,” he contends that the fees paid by Plan participants would be even higher 24 than what he can calculate now. Id. 25 For his second imprudence theory, he alleges that defendants’ deficient decision-making 26

27 3 Wehner no longer challenges the Plan’s retention of the Roche U.S. Small and Mid-Cap Equity 1 concerning the Roche TDFs began with the selection of Russell as the advisor and investment 2 manager of those funds. Id. ¶¶ 129–31. Russell is a firm with which defendants have a “long- 3 standing relationship” through the Master Trust, which has paid millions of dollars in 4 compensation to Russell for investment management services provided to various retirement plans 5 within the Master Trust. Id. Defendants’ decision to select and retain Russell to make critical 6 decisions on the appropriate asset mix for the Roche TDFs was allegedly imprudent “given 7 Russell’s reputation and lack of standing in the target date fund market.” Id. ¶¶ 134–36. 8 Wehner further alleges that the Roche TDFs’ performance cannot be evaluated against 9 defendants’ custom benchmark, the Roche Target Date Fund Index, because such “custom 10 benchmarks are imperfect as an evaluative tool as they fail to demonstrate how the investment is 11 performing relative to peers.” Id. ¶¶ 142–43. Rather, when evaluated against his proposed 12 benchmarks— the S&P Target Date Indices (“S&P Indices”) and six retail TDFs (Vanguard, T. 13 Rowe Price, American Funds, Fidelity, JPMorgan, and BlackRock LifePath)—the Roche TDFs 14 have been consistently underperforming since at least 2013. Id. ¶¶ 144–55.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Wehner v. Genentech, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/wehner-v-genentech-inc-cand-2021.